A Multicenter Observational Study of an Integrated Traditional Chinese and Western Medicine Care Model in Post-Acute Treatment of Frail Elderly Patients
1 other identifier
interventional
20
1 country
1
Brief Summary
Exploring the Impact and Effectiveness of an Integrated Traditional Chinese and Western Medicine Treatment Model in Post-Acute Care for Frail Older Patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 28, 2025
CompletedFirst Submitted
Initial submission to the registry
August 14, 2025
CompletedFirst Posted
Study publicly available on registry
August 22, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 31, 2027
August 22, 2025
August 1, 2025
1.4 years
August 14, 2025
August 21, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Study of Osteoporotic Fractures
Measured by the Study of Osteoporotic Fractures (SOF Index) ,score of 0\~2 : 0=robust,1 =prefrail,2= frail.
At baseline, End of treatment(4 weeks)
comprehensive geriatric assessment
Measured by comprehensive geriatric assessment(CGA)
At baseline, End of treatment(4 weeks)
Body Constitution Questionnaire / Constitution in Chinese Medicine Questionnaire
Measured by Body Constitution Questionnaire(BCQ) / Constitution in Chinese Medicine Questionnaire(CCMQ)
At baseline, End of treatment(4 weeks)
Secondary Outcomes (5)
Height
At baseline, End of treatment(4 weeks)
Weight
At baseline, End of treatment(4 weeks)
Calf circumference
At baseline, End of treatment(4 weeks)
Grip strength
At baseline, End of treatment(4 weeks)
Gait speed
At baseline, End of treatment(4 weeks)
Study Arms (1)
intervention group
EXPERIMENTAL1. Oral Chinese herbal medicine or decoction 2. Acupuncture or laser acupuncture treatment 3. Acupoint massage 4. Traditional Chinese Medicine Cake Acupoint Application 5. Nursing and health education and guidance 6. Dietary hygiene education 7. Lifestyle health education and sports rehabilitation
Interventions
1. Oral Chinese herbal medicine or decoction: prescribe Chinese medicine based on syndrome differentiation and treatment of the patient's condition. 2. Acupuncture or laser acupuncture treatment: Traditional Chinese medicine practitioners select acupuncture points to treat based on the patient's condition, and treat them once a week. 3. Acupoint massage: Select treatment acupoints and techniques according to the patient's condition, 20 minutes at a time. 4. Traditional Chinese Medicine Cake Acupoint Application: Warm Navel Cream to the CV-4 (Guanyuan) acupoint, the application time is 2 to 4 hours. 5. Nursing and health education and guidance. 6. Dietary hygiene education: personalized western nutrition and TCM dietary guidance suggestions based on TCM constitution syndromes. 7. Lifestyle health education and sports rehabilitation: Playing Baduanjin, ten skilled hand exercise, and health preservation videos, and providing personalized TCM exercise recommendations.
Eligibility Criteria
You may qualify if:
- Elderly patients aged ≥75 years.
- A history of at least one of the following conditions: Parkinson's disease, chronic obstructive pulmonary disease (COPD), mild dementia, or chronic kidney disease at stage 3 or above.
- Hospitalized due to an acute illness (length of hospital stay \>72 hours).
- Functional decline within one month after completion of treatment.
- Clinical Frailty Scale (CFS) score of 5-7 (indicating moderate or greater frailty, with retained rehabilitation potential).
- Can answer clinical questionnaires and scales.
You may not qualify if:
- Medically unstable (requiring intensive medical interventions, diagnostic testing, or supplemental oxygen).
- Unable to cooperate with treatment or communication.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
China Medical University Hospital
Taichung, 403, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 14, 2025
First Posted
August 22, 2025
Study Start
July 28, 2025
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
March 31, 2027
Last Updated
August 22, 2025
Record last verified: 2025-08